MENLO PARK, Calif. – ProDx Health has announced the appointment of Dr. Charlotte Gaydos to its Advisory Board, marking a significant addition to the company’s scientific leadership team.
Dr. Gaydos, a Professor Emerita of Infectious Diseases at Johns Hopkins University, brings decades of expertise in sexually transmitted infection (STI) diagnostics and respiratory disease research. Throughout her career, she has led multiple FDA clinical trials, advanced the development of DNA amplification tests, and served as world president of the International Union Against Sexually Transmitted Infections(IUSTI).
“We’re honored to welcome Dr. Charlotte Gaydos to our Advisory Board,” said ProDx Health Founder and CEO, Dr. K. “Her ground breaking work at Johns Hopkins and her leadership in STI diagnostics bring invaluable insight to our mission of advancing point-of-care testing and community health.”
The Advisory Board at ProDx Health meets monthly, guiding the company on key areas including:
- Scientific innovation and research strategy
- Community testing and outreach initiatives
- Industry best practices and evolving health needs
Dr. Gaydos’ expertise will play a vital role in shaping the future of accessible diagnostic solutions, particularly as ProDx Health continues to focus on point-of-care testing that empowers both patients and healthcare providers.
For more details, visit ProDxHealth.com or follow the company updates on X.com.
